Effects of Telerehabilitation-Based Motor and Cognitive Dual-Task Exercise in Patients With Parkinson's Disease

January 27, 2026 updated by: Ebru Akbuğa Koç, Yeditepe University

Comparison of the Effects of Telerehabilitation-Based Motor and Cognitive Dual-Task Exercise in Patients With Parkinson's Disease - A Randomized Controlled Study

The ability to respond to multiple stimuli is impaired in Parkinson's patients. Traditional rehabilitation approaches focus only on balance and gait training, but individuals with Parkinson's disease need to perform multiple tasks in daily life.

Study Overview

Status

Completed

Conditions

Detailed Description

The dual-task (DT) methodology aims to perform two tasks simultaneously. There is no study in which motor and cognitive dual-task exercises are given together and followed up remotely in elderly individuals with PD.

Therefore, it was aimed to compare the effects of telerehabilitation method and motor and cognitive dual-task exercises on cognitive function, balance, walking, fall risk and quality of life in individuals with Parkinson's Disease.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Being diagnosed with idiopathic Parkinson's Disease

    • Getting at least 21 points from the Montreal Cognitive Assessment Scale test
    • Stability of drug therapy taken in the last 1 month
    • Being in the "ten" period of the patients
    • Being able to walk independently on flat ground (3 and above according to Functional Ambulation Classification)

Exclusion Criteria:

  • • Serious hearing or vision problems

    • Having other neurological, cardiovascular or orthopedic disorders that may prevent walking
    • Any other neurological disorder (eg dementia, cerebrovascular disease)
    • Having an education level of less than 5 years
    • Patients with a pacemaker
    • Having vascular lower extremity pathologies
    • Not having internet access with a smart phone or computer

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Motor-Motor Dual Task Training Exercises
Motor-Motor Dual Task Physical Exercises will be given to the participants
Only physical exercise and motor dual tasks will be given
Active Comparator: Cognitive-Motor Dual Task Training Exercises
Cognitive-Motor Dual Task Physical Exercises will be given to the participants
Only physical exercise and motor dual tasks will be given
Active Comparator: Structured exercise program
Physical exercise will be given to the participants
Only physical exercise and motor dual tasks will be given

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Parkinson's Disease Quality of Life Questionnaire
Time Frame: 8 weeks
Parkinson's Disease Quality of Life Questionnaire
8 weeks
Montreal Cognitive Assessment Scale (MoCA)
Time Frame: 8 weeks
Montreal Cognitive Assessment Scale (MoCA)
8 weeks
Berg Balance Scale (BBS)
Time Frame: 8 weeks
Berg Balance Scale (BBS)
8 weeks
10 meter walking speed test
Time Frame: 8 weeks
10 meter walking speed test
8 weeks
Timed Up And Go Test
Time Frame: 8 weeks
Timed Up And Go Test
8 weeks
Fall Efficiency Scale - International
Time Frame: 8 weeks
Fall Efficiency Scale - International
8 weeks
Five Times Sit to Stand Test
Time Frame: 8 weeks
Five Times Sit to Stand Test
8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yeditepe University, Yeditepe University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 30, 2023

Primary Completion (Actual)

July 14, 2023

Study Completion (Actual)

August 1, 2023

Study Registration Dates

First Submitted

May 30, 2023

First Submitted That Met QC Criteria

May 30, 2023

First Posted (Actual)

June 8, 2023

Study Record Updates

Last Update Posted (Actual)

January 29, 2026

Last Update Submitted That Met QC Criteria

January 27, 2026

Last Verified

May 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parkinson Disease

Clinical Trials on Motor-Motor Dual Task Physical Exercises

Subscribe